Insulet Corp, connu pour son système d'injection d'insuline Omnipod, a connu une augmentation des investissements institutionnels, sous la direction de Mizuho Securities USA. Insulet Corp, known for its Omnipod insulin delivery system, saw a surge in institutional investments, led by Mizuho Securities USA.

Insulet Corp, qui fabrique des systèmes d'administration d'insuline comme l'Omnipod, a vu une forte augmentation des investissements institutionnels au cours du troisième trimestre. Insulet Corp, which makes insulin delivery systems like the Omnipod, saw a big increase in institutional investments during the third quarter. Mizuho Securities USA LLC a mené la voie en augmentant sa participation de 5 928,1%, maintenant propriétaire d'actions d'une valeur de 75,8 millions de dollars. Mizuho Securities USA LLC led the way by boosting its stake by 5,928.1%, now owning $75.8 million worth of shares. D'autres investisseurs ont également augmenté leurs participations. Other investors also increased their holdings. L'action, qui a ouvert ses portes à 260,12 $ vendredi, a un plafond de marché de 18,25 milliards de dollars et a reçu des notes principalement positives de la part des analystes. The stock, which opened at $260.12 on Friday, has a market cap of $18.25 billion and has received mostly positive ratings from analysts.